| AKTX Stock | | | USD 1.14 0.11 10.68% |
Akari Therapeutics financial indicator trend analysis is way more than just evaluating Akari Therapeutics PLC prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Akari Therapeutics PLC is a good investment. Please check the relationship between Akari Therapeutics Begin Period Cash Flow and its Stock Based Compensation accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Akari Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
Begin Period Cash Flow vs Stock Based Compensation
Begin Period Cash Flow vs Stock Based Compensation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Akari Therapeutics PLC Begin Period Cash Flow account and
Stock Based Compensation. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Akari Therapeutics' Begin Period Cash Flow and Stock Based Compensation is 0.91. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Stock Based Compensation in the same time period over historical financial statements of Akari Therapeutics PLC, assuming nothing else is changed. The correlation between historical values of Akari Therapeutics' Begin Period Cash Flow and Stock Based Compensation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Akari Therapeutics PLC are associated (or correlated) with its Stock Based Compensation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Stock Based Compensation has no effect on the direction of Begin Period Cash Flow i.e., Akari Therapeutics' Begin Period Cash Flow and Stock Based Compensation go up and down completely randomly.
Correlation Coefficient | 0.91 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.
Most indicators from Akari Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Akari Therapeutics PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Akari Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
Selling General Administrative is likely to drop to about 7.6
M in 2024.
Tax Provision is likely to drop to about (3
M) in 2024
Akari Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Akari Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Akari Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Akari Stock Analysis
When running Akari Therapeutics' price analysis, check to
measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.